Recombinant AREG stimulated RA-FLS to express these cytokines in a dose-dependent manner, and the EGFR-tyrosine kinase inhibitor genistein suppressed the AREG-dependent expression in a dose-dependent manner. Here, EGFR is linked to rheumatoid arthritis.